A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1997
10/14/1997	US5677150 Antibodies produced from lipopolysaccharide-stimulated monocyte/macprophage cell lines
10/14/1997	US5677147 HIV-2 virus variants
10/14/1997	US5677143 Isolated nucleic acid encoding amino acid sequence of cellular protein
10/14/1997	US5677137 Method to identify immunocompromised patients at high risk for cryptococcosis
10/14/1997	US5677132 Using antibody; immunoassay of psychoactive drug
10/14/1997	US5676953 Intestinal protozoal vaccines
10/14/1997	US5676952 Genetic engineered vaccine
10/14/1997	US5676951 Bovine herpesvirus type 1 deletion mutants and vaccines
10/14/1997	US5676950 Enterically administered recombinant poxvirus vaccines
10/14/1997	US5676946 Phospholipase C homolog
10/14/1997	US5676940 Method of reducing immunoglobulin E responses
10/09/1997	WO1997037044A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
10/09/1997	WO1997037031A1 Parapoxvirus vectors
10/09/1997	WO1997037026A1 Novel compounds
10/09/1997	WO1997037020A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use
10/09/1997	WO1997037005A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	WO1997037004A1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
10/09/1997	WO1997037001A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
10/09/1997	WO1997037000A1 Animal cells and processes for the replication of influenza viruses
10/09/1997	WO1997036932A1 Modified/chimeric superantigens and their use
10/09/1997	WO1997036929A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH)
10/09/1997	WO1997036926A1 Growth differentiation factor-14
10/09/1997	WO1997036924A1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use
10/09/1997	WO1997036923A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
10/09/1997	WO1997036922A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997	WO1997036919A2 Cytokine designated lerk-8
10/09/1997	WO1997036914A1 High molecular weight surface proteins of non-typeable haemophilus
10/09/1997	WO1997036612A1 Anti-cryptosporidium parvum preparations
10/09/1997	WO1997036601A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	WO1997031115A3 Synthetic hiv genes
10/09/1997	WO1997026912A3 Anti-cd18 antibodies for use against stroke
10/09/1997	DE19613691A1 Arzneimittel für die Behandlung von Tumorerkrankungen Drugs for the treatment of tumor diseases
10/09/1997	CA2259133A1 High molecular weight surface proteins of non-typeable haemophilus
10/09/1997	CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	CA2250814A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	CA2250394A1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
10/09/1997	CA2250110A1 Growth differentiation factor-14
10/09/1997	CA2250041A1 Parapoxvirus vectors
10/09/1997	CA2249716A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997	CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	CA2248985A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
10/08/1997	EP0799893A1 Defective viral particles obtained in vivo or ex vivo as vaccine
10/08/1997	EP0799873A1 Composition for a non-wettable coating, process for treating glazing pane with this composition and the products obtained
10/08/1997	EP0799835A2 Anti-fibroblast growth factor-8 monoclonal antibody
10/08/1997	EP0799613A1 Container with freeze-dried vaccine components
10/08/1997	EP0799315A2 Telomerase protein component
10/08/1997	EP0799312A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
10/08/1997	EP0799309A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
10/08/1997	EP0799244A1 A bifunctional or bivalent antibody fragment analogue
10/08/1997	EP0799241A1 Peptides having immunomodulatory activity
10/08/1997	EP0799058A1 Improvements in or relating to endometrial function
10/08/1997	EP0799053A1 Enhanced immunogenic vaccine
10/08/1997	EP0482089B1 Method of treating autoimmune uveoretinitis in human
10/08/1997	CN1161715A DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector
10/07/1997	US5674994 Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors
10/07/1997	US5674984 Method for isolation of unclipped HIV envelope protein
10/07/1997	US5674980 Fusion protein comprising tat-derived transport moiety
10/07/1997	US5674978 Peptides derived from glutamic acid decarboxylase
10/07/1997	US5674749 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof
10/07/1997	US5674736 Salmonella virulence genes
10/07/1997	US5674735 Isolated dna fragment encoding native equine herpes virus-4 glycoproteins (ehv-4 gh, gc); vaccines
10/07/1997	US5674724 Mutating the phoq gene to cause a gene under control of phop/phoq regulatort region to be expressed constitutively
10/07/1997	US5674709 Pseudorabies virus protein
10/07/1997	US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997	US5674676 HCV peptide antigens and method of determining HCV
10/07/1997	US5674503 Peptides capable of eliciting an immune response to leishmaniasis and methods of using the same
10/07/1997	US5674502 Cross-reactive influenza a immunization
10/07/1997	US5674500 Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus mutants
10/07/1997	US5674499 Equine herpesvirus gene 15 mutants
10/07/1997	US5674495 Antigen formulated in alginate gel delivery vehicle for oral administration
10/07/1997	US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/07/1997	US5674486 Stimulating immune response against tumor antigen by immunizing with genetic engineered cells
10/07/1997	US5674484 Vaccine antigens for treatment of poultry
10/02/1997	WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997	WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	WO1997035989A2 Cyclic nucleotide phosphodiesterase
10/02/1997	WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997	WO1997035976A2 Epidermal differentiation factor
10/02/1997	WO1997035962A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
10/02/1997	WO1997035887A1 Precursors of catalytic antibodies
10/02/1997	WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997	WO1997035884A1 Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
10/02/1997	WO1997035879A1 Myelin oligodendrocyte glycoprotein peptides and uses thereof
10/02/1997	WO1997035870A1 Growth factor htter36
10/02/1997	WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
10/02/1997	WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997	WO1997035613A1 Method of producing immunogenic products and vaccines
10/02/1997	WO1997035612A1 Functional fragment antigen of tetanus toxin and tetanus vaccine
10/02/1997	WO1997035611A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997	WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997	WO1997035595A1 Egg anti-inflammatory composition, method of isolation and use
10/02/1997	WO1997035490A1 Colostrum food supplement
10/02/1997	WO1997031117A3 A human cytomegalovirus combined antigen and its use
10/02/1997	WO1997026910A3 Tumour vaccine for immunotherapy of malignant tumours
10/02/1997	WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997	WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997	DE19612967A1 Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren Method for replication of influenza viruses in cell culture, as well as the influenza viruses obtainable by the process
10/02/1997	DE19612966A1 Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren Animal cells and processes for replication of influenza viruses

1 ... 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 ... 1823